Major Growth Driver Identified in 2025 Gene Therapy Market: Rising Cancer Incidences Drive Growth In The Gene Therapy Market

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Gene Therapy Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In recent times, the gene therapy market has seen substantial growth. The market value is predicted to increase from $12.52 billion in 2024 to $16.36 billion in 2025, indicating a compound annual growth rate (CAGR) of 30.7%. The significant growth during the historic period can be credited to the increase in pharmaceutical research and development expenses, the surge in public-private cooperation, government funding, and the escalating incidences of spinal muscular atrophy.

Gene Therapy Market Size Forecast: What's the Projected Valuation by 2029?
A surge in the gene therapy market size is anticipated in the coming years, expanding to an estimated level of "$31.48 billion in 2029 with a compound annual growth rate (CAGR) of 17.8%. Several contributing factors for the rise during this forecasted period include an increase in cancer incidences, growth in the elderly population, augmented investment in R&D in the pharmaceutical field, and heightened emphasis on gene therapy. The imminent trend includes securing regulatory permissions to enhance business operations, strengthening business activities via strategic alliances and partnerships, extending business capabilities via strategic takeovers, and bolstering operational abilities through business expansion.

View the full report here:
https://www.thebusinessresearchcompany.com/report/genes-therapy-global-market-report

What Are the Drivers Transforming the Gene Therapy Market?
The escalating prevalence of cancer and other related diseases is significantly increasing the need for potent treatments, thereby fuelling the expansion of the gene therapy market. The global escalation in cancer cases is anticipated to have a positive effect on the growth of the gene therapy market within the forecasted time frame. For instance, the American Cancer Society estimated in January 2022 that around 1.9 million new cancer cases and roughly 609,360 cancer-induced deaths would occur in the US, translating to about 1,670 deaths every day. The top four widespread types of cancer globally, namely lung, prostate, bowel, and female breast cancer, represent 43 percent of all new cancer diagnoses. Consequently, the global increase in the rate of cancer incidences is expected to stimulate higher demand for the gene therapy market in the near future. Amongst various treatments, gene therapy has proved to be highly effective in oncology. This therapy involves the introduction of new genes into cancer cells or adjacent tissue to induce their death or inhibit the cancer's growth.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3395&type=smp

What Trends Will Shape the Gene Therapy Market Through 2029 and Beyond?
The presence of machine learning and artificial intelligence is increasingly becoming recognizable in the gene therapy market. These technologies mimic human intelligence in machines, thereby enhancing their natural intelligence. Acting as a subset of AI, machine learning plays a significant role in enabling businesses involved in gene therapy to conduct comprehensive data analysis, bridge the understanding gap in tumor-immune cell interactions and improve tissue sample evaluations, which often incite disagreements among various examiners. In May 2023, the US-oriented life science software firm, Form Bio, introduced FORMsightAI, an innovative AI-based resolution set designed to forecast and boost the manufacture of cell and gene therapy structures. This comprehensive solution fuses state-of-the-art, flexible AI models with the foundational platform of Form Bio and a proficient team of computational life science experts, proficient in fields like biology, bioinformatics, and data science. FORMsightAI is designed to tackle prevalent problems suffered by cell and gene therapy developers, such as construct truncations and production contaminations - primary factors that result in unsatisfactory manufacturing yields, protracted time to market, and clinical safety concerns.

Which Segments in the Gene Therapy Market Offer the Most Profit Potential?
The gene therapy market covered in this report is segmented -

1) By Gene Therapy Type: Germline Therapy, Somatic Cell Therapy
2) By Vector: Viral Vector, Non-Viral Vector
3) By Application: Oncology, Orphan Disease, Knee Osteoarthritis, Neurological Disorders
4) By End Users: Biopharmaceutical Companies, Research Institutes, Other End Users

Subsegments:
1) By Germline Therapy: Inherited Disease Treatment, Genetic Modification Of Embryos, Gene Editing Techniques, Ethical And Regulatory Considerations
2) By Somatic Cell Therapy: Cancer Gene Therapy, Monogenic Disorder Treatment, Gene Replacement Therapy, RNA-Based Therapies, Gene Editing Techniques

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=3395&type=smp

Which Firms Dominate the Gene Therapy Market by Market Share and Revenue in 2025?
Major companies operating in the gene therapy market include UniQure NV, REGENXBIO Inc., Bristol-Myers Squibb, BioMarin Pharmaceuticals Inc., Jazz Pharmaceuticals Inc., Biocon, Cipla, EdiGene Inc, Takeda Pharmaceutical, Daiichi Sankyo Company, Mitsubishi Tanabe Pharma, Merck, GE Healthcare, Lonza, Pfizer, Cellular Biomedicine Group, GenScript, Albumedix Ltd, Catalent, Freeline Therapeutics, DiNAQOR AG, Vivet Therapeutics, Allergan, Amgen, Biocad, Celgene Corporation, Johnson & Johnson, Eli Lilly and Company, AstraZeneca, Bayer AG, Juno Therapeutics, Allogene Therapeutics, Bluebird Bio, Regen BioPharma, Bellicum, Biotchpharma, BrainStorm Cell Therapeutics, Pluristem, Sanofi

Which Regions Offer the Highest Growth Potential in the Gene Therapy Market?
North America was the largest region in the gene therapy market in 2024. The regions covered in the gene therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3395

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Speak With Our Expert:
Saumya Sahay
Americas +1 310-496-7795,
Asia +44 7882 955267 & +91 8897263534,
Europe +44 7882 955267
Email:saumyas@tbrc.info
The Business Research Company -www.thebusinessresearchcompany.com
Follow Us On:
LinkedIn:https://in.linkedin.com/company/the-business-research-company

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.